ImpediMed Future Growth
Future criteria checks 2/6
ImpediMed is forecast to grow earnings and revenue by 51.2% and 39.8% per annum respectively. EPS is expected to grow by 59.2% per annum. Return on equity is forecast to be -10.1% in 3 years.
Key information
51.2%
Earnings growth rate
59.2%
EPS growth rate
| Medical Equipment earnings growth | 16.2% |
| Revenue growth rate | 39.8% |
| Future return on equity | -10.1% |
| Analyst coverage | Low |
| Last updated | 16 Apr 2024 |
Recent future growth updates
Recent updates
ImpediMed (ASX:IPD) Is In A Good Position To Deliver On Growth Plans
Mar 05
Companies Like ImpediMed (ASX:IPD) Are In A Position To Invest In Growth
Nov 23Is ImpediMed (ASX:IPD) In A Good Position To Deliver On Growth Plans?
Jul 11We Think ImpediMed (ASX:IPD) Needs To Drive Business Growth Carefully
Mar 27Here's Why We're Not Too Worried About ImpediMed's (ASX:IPD) Cash Burn Situation
Sep 28We're Not Worried About ImpediMed's (ASX:IPD) Cash Burn
Jun 10A Look At The Fair Value Of ImpediMed Limited (ASX:IPD)
Feb 01We Think ImpediMed (ASX:IPD) Can Afford To Drive Business Growth
Aug 25Here's Why We're Not Too Worried About ImpediMed's (ASX:IPD) Cash Burn Situation
Apr 06Analysts Expect Breakeven For ImpediMed Limited (ASX:IPD) Before Long
Feb 12
ImpediMed's (ASX:IPD) Stock Price Has Reduced 88% In The Past Five Years
Jan 08How Does ImpediMed's (ASX:IPD) CEO Salary Compare to Peers?
Nov 25Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2026 | 32 | -2 | -1 | 2 | 1 |
| 6/30/2025 | 19 | -14 | -17 | -13 | 2 |
| 6/30/2024 | 11 | -21 | -23 | -18 | 2 |
| 12/31/2023 | 10 | -19 | -18 | -13 | N/A |
| 9/30/2023 | 11 | -20 | -21 | -15 | N/A |
| 6/30/2023 | 11 | -21 | -24 | -18 | N/A |
| 3/31/2023 | 11 | -21 | -25 | -20 | N/A |
| 12/31/2022 | 11 | -22 | -27 | -22 | N/A |
| 9/30/2022 | 11 | -21 | -24 | -19 | N/A |
| 6/30/2022 | 11 | -20 | -21 | -16 | N/A |
| 3/31/2022 | 10 | -20 | -19 | -14 | N/A |
| 12/31/2021 | 10 | -19 | -17 | -13 | N/A |
| 9/30/2021 | 9 | -20 | -16 | -13 | N/A |
| 6/30/2021 | 8 | -21 | -16 | -13 | N/A |
| 3/31/2021 | 7 | -20 | -17 | -15 | N/A |
| 12/31/2020 | 6 | -19 | -18 | -16 | N/A |
| 9/30/2020 | 6 | -20 | -20 | -18 | N/A |
| 6/30/2020 | 6 | -21 | -21 | -19 | N/A |
| 12/31/2019 | 5 | -25 | -22 | -20 | N/A |
| 9/30/2019 | 5 | -24 | -22 | -20 | N/A |
| 6/30/2019 | 4 | -24 | -22 | -20 | N/A |
| 12/31/2018 | 4 | -25 | -23 | -21 | N/A |
| 9/30/2018 | 3 | -26 | -24 | -22 | N/A |
| 6/30/2018 | 3 | -27 | -25 | -23 | N/A |
| 3/31/2018 | 4 | -28 | N/A | N/A | N/A |
| 12/31/2017 | 4 | -28 | -26 | -26 | N/A |
| 9/30/2017 | 5 | -28 | N/A | -26 | N/A |
| 6/30/2017 | 6 | -28 | N/A | -26 | N/A |
| 3/31/2017 | 6 | -28 | N/A | -25 | N/A |
| 12/31/2016 | 6 | -29 | N/A | -25 | N/A |
| 9/30/2016 | 6 | -27 | N/A | -24 | N/A |
| 6/30/2016 | 6 | -26 | N/A | -22 | N/A |
| 3/31/2016 | 6 | -23 | N/A | -19 | N/A |
| 12/31/2015 | 5 | -20 | N/A | -16 | N/A |
| 9/30/2015 | 5 | -17 | N/A | -13 | N/A |
| 6/30/2015 | 5 | -15 | N/A | -11 | N/A |
| 3/31/2015 | 4 | -13 | N/A | -9 | N/A |
| 12/31/2014 | 4 | -10 | N/A | -8 | N/A |
| 9/30/2014 | 4 | -9 | N/A | -7 | N/A |
| 6/30/2014 | 4 | -8 | N/A | -7 | N/A |
| 3/31/2014 | 3 | -7 | N/A | -6 | N/A |
| 12/31/2013 | 3 | -7 | N/A | -6 | N/A |
| 9/30/2013 | 3 | -8 | N/A | -7 | N/A |
| 6/30/2013 | 3 | -8 | N/A | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IPD is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: IPD is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: IPD is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: IPD's revenue (39.8% per year) is forecast to grow faster than the Australian market (4.7% per year).
High Growth Revenue: IPD's revenue (39.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IPD is forecast to be unprofitable in 3 years.